Clinical trial
An External Evaluation of a Metagenomic Next Generation Sequencing Workflow for Infection Diagnosis Using Oxford Nanopore Sequencing.
NCT04864873 is registered in ClinicalTrials.gov with Capital and Coast District Health board as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An External Evaluation of a Metagenomic Next Generation Sequencing Workflow for Infection Diagnosis Using Oxford Nanopore Sequencing.
- Lead sponsor
- Capital and Coast District Health board
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 1, 2021
- Completion date
- May 31, 2022
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.